Sotatercept Endorsed for PAH by ICER

Source link :

LOCATION — In a new report, the Midwest Institute for Clinical and Economic Review’s (ICER) Comparative Effectiveness Public Advisory Council concluded that the Merck drug sotatercept, currently under review by the US Food and Drug Administration (FDA), has a high certainty of at least a small net health benefit to patients with pulmonary arterial hypertension […]

Author : News Health

Publish date : 2023-12-06 12:12:20

Copyright for syndicated content belongs to the linked Source.